Tyme Technologies to Present at Jefferies Virtual Global Healthcare Conference on November 17-19, 2020

BEDMINSTER, N.J.–(BUSINESS WIRE)—- $TYME–Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that its leadership will present at the Jefferies Virtual Global Healthcare Conference on November 17-19. In one-on-one sessions, the Company will present its corporate overview for fiscal year 2021 with a special focus on multiple growth opportunities driven by advances in the science of cancer cell metabolism, SM-88 (race